Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion type Assertion NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_head.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion description "[We investigated dopaminergic inhibition of CD4+CD25(high) regulatory T lymphocytes (Treg) in relapsing-remitting multiple sclerosis (MS) patients treated with interferon (IFN)-?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion evidence source_evidence_literature NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion SIO_000772 22472872 NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion wasDerivedFrom befree-20140225 NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.
- NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_assertion wasGeneratedBy ECO_0000203 NP870044.RA9E3E-AVSBJrqBFcvD0l3fl-Y3dgea0FYlLzF3_UVgPk130_provenance.